Split History
ETFs Holding CBLI »    CBLI Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Cleveland BioLabs is a biopharmaceutical company developing approaches to activate the immune system and address medical needs. Co.'s proprietary platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Co.'s product candidate, Entolimod, a Toll-like receptor 5 (TLR5) agonist, which Co. is developing as a medical radiation countermeasure for reducing the risk of death from Acute Radiation Syndrome. Mobilan is a recombinant non-replicating adenovirus that directs expression of TLR5 and its agonistic ligand, a secretory non-glycosylated version of entolimod Co. is also developing through its subsidiary, Panacela Labs, Inc. According to our CBLI split history records, Cleveland BioLabs has had 1 split.
CBLI split history picture
Cleveland BioLabs (CBLI) has 1 split in our CBLI split history database. The split for CBLI took place on January 28, 2015. This was a 1 for 20 reverse split, meaning for each 20 shares of CBLI owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.

When a company such as Cleveland BioLabs conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the CBLI split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cleveland BioLabs shares, starting with a $10,000 purchase of CBLI, presented on a split-history-adjusted basis factoring in the complete CBLI split history. CBLI split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 12/10/2009
End date: 12/09/2019
Start price/share: $70.80
End price/share: $0.74
Dividends collected/share: $0.00
Total return: -98.95%
Average Annual Total Return: -36.62%
Starting investment: $10,000.00
Ending investment: $104.47
Years: 10.00
Date Ratio
01/28/20151 for 20
CBLI is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

CBM Split History
CBMX Split History
CBRX Split History
CCM Split History
CDXC Split History
CELG Split History
CERE Split History
CERU Split History
CGIX Split History
CGNT Split History

Also explore: CBLI shares outstanding history

QuickLogic Corporation (QUIK)
iMedia Brands, Inc. (IMBI)
Akers Biosciences, Inc. (AKER)
NeuroMetrix, Inc. (NURO)
TRACON Pharmaceuticals (TCON)
SELLAS Life Sciences Group, Inc. (SLS)
Tonix Pharmaceuticals Holding Corp. (TNXP)
Camber Energy, Inc. (CEI)
Cancer Genetics, Inc. (CGIX)
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3X Shares (GUSH)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

CBLI Insider Buying

CBLI Split History | www.SplitHistory.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.